Historic
growth
in
DOJ
fines
levied
against

     the
Pharmaceutical
Industry
for

   inappropriate
marketing
activities.
...
Upcoming SlideShare
Loading in …5
×

Historic Growth In Doj Fines Levied Against The Pharmaceutical Industry For Inappropriate Marketing Activities

920 views

Published on

A quick and scary chart of fines levied against Big Pharma for inappropriate marketing activities.

Published in: Business, News & Politics
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
920
On SlideShare
0
From Embeds
0
Number of Embeds
7
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Historic Growth In Doj Fines Levied Against The Pharmaceutical Industry For Inappropriate Marketing Activities

  1. 1. Historic
growth
in
DOJ
fines
levied
against
 the
Pharmaceutical
Industry
for
 inappropriate
marketing
activities.
 
 4000 3 fines YTD 3500 3000 Fines since 1999 levied for improper marketing activities 2500 Millions ($) 2000 1500 1 fine or less 5 fines 1000 500 2 fines 0 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Year 
 Since
1999
the
volume
and
cost
of
fines
levied
against
the
 Pharmaceutical
Industry
for
inappropriate
marketing
activities
has
 grown
significantly.

 The
cost
to
the
industry
is
now
more
than
most
new
products
will
 generate
in
revenue
during
the
product’s
lifetime.
 Can
you
afford
not
to
protect
your
company
and
it’s
shareholders?
 Ask
us
how
to
prevent
even
the
most
accidental
infractions
that
can
cost
 your
organization
millions.
 
 
 Advantage
Management
Solutions,
Inc.
 sales@advantagems.com
 


×